StockData
AnaptysBio, Inc logo

AnaptysBio, Inc (ANAB) stock

ANABNasdaqPharmaceutical PreparationsFiscal year ends June 30
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 9/30
$49.24+2.63 (+5.64%)

Close on Oct 19, 2026Market cap $2.28BP/E –Yield –

AnaptysBio price to book ratio

The price-to-book ratio is market cap divided by shareholders' equity.

AnaptysBio's price to book ratio was 138.3× on Oct 19, 2026, against 6.4× a year earlier. Over the last 5 years it ranged from 1.1× to 160.2×, with a median of 2.3×.

Price to Book Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Oct 19, 2026138.3×+123.7
2025Jul 31, 202514.6×+11.4
2024Dec 31, 20243.2×+0.0
2023Dec 29, 20233.2×+1.0
2022Dec 30, 20222.1×+0.5
2021Dec 31, 20211.7×+0.6
2020Dec 31, 20201.1×+0.4
2019Dec 31, 20190.7×−1.6
2018Dec 31, 20182.3×−11.3
2017Dec 29, 201713.6×–

More AnaptysBio figures

See a number that looks wrong?